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ABSTRACT
The DNA damage response is vigorously activated
by DNA double-strand breaks (DSBs). The chief mo-
bilizer of the DSB response is the ATM protein kinase.
We discovered that the COP9 signalosome (CSN) is
a crucial player in the DSB response and an ATM tar-
get. CSN is a protein complex that regulates the ac-
tivity of cullin ring ubiquitin ligase (CRL) complexes
by removing the ubiquitin-like protein, NEDD8, from
their cullin scaffold. We find that the CSN is phys-
ically recruited to DSB sites in a neddylation-
dependent manner, and is required for timely repair
of DSBs, affecting the balance between the two major
DSB repair pathways––nonhomologous end-joining
and homologous recombination repair (HRR). The
CSN is essential for the processivity of deep end-
resection––the initial step in HRR. Cullin 4a (CUL4A)
is recruited to DSB sites in a CSN- and neddylation-
dependent manner, suggesting that CSN partners
with CRL4 in this pathway. Furthermore, we found
that ATM-mediated phosphorylation of CSN subunit
3 on S410 is critical for proper DSB repair, and that
loss of this phosphorylation site alone is sufficient
to cause a DDR deficiency phenotype in the mouse.
This novel branch of the DSB response thus signifi-
cantly affects genome stability.
INTRODUCTION
The DNA damage response (DDR) constitutes a central
axis in themaintenance of genome stability (1–3). TheDDR
is an extensive signaling network, based on a core of dedi-
cated damage response proteins that is assisted by a mul-
titude of other proteins, which are temporarily recruited
from various pathways to serve the DDR. The DDR is
activated most vigorously by DNA double-strand breaks
(DSBs). The DSB response activates DNA repair mech-
anisms and special cell cycle checkpoints, thereby modu-
lating numerous cellular circuits while the damage is re-
paired (1,3). Its early phase is marked by the recruitment
of a heterogeneous group of proteins to DSB sites, collec-
tively dubbed ‘sensors’ or ‘mediators’. These proteins coa-
lesce into highly ordered structures, visible as nuclear foci
at the break sites (4), whose activity leads to chromatin re-
organization and transcription arrest at the sites of DNA
damage and sets the scene for DSB repair (5). This activity
is regulated by extensive protein post-translational modifi-
cations, such as phosphorylation and ubiquitylation, which
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occur on the sensors/mediators as well as on chromatin pro-
teins including core histones (4–8).DSB repair is carried out
under the precise regulation of several repair mechanisms,
divided into two branches: classical nonhomologous end-
joining (NHEJ) and its sub-pathways, and homologous re-
combination repair (HRR) (3). Briefly, NHEJ is based on
direct ligation of DSB ends following their initial process-
ing; it takes place throughout the cell cycle via several dif-
ferent mechanisms, and is considered mutagenic. HRR, on
the other hand, is error-free; it is based on recombination
between the damaged DNA molecule and an undamaged
sister molecule, and can hence occur only at the late S or G2
phases of the cell cycle. Maintaining the balance between
these two repair pathways, which can potentially compete
for repair of the same lesion, is important for efficient and
timely DSB repair (9).
The chief mobilizer of the DSB response is the homeo-
static, multi-functional protein kinase ATM, whose activity
is markedly enhanced followingDSB induction (10,11). Ac-
tivatedATMphosphorylates numerous effectors in the vari-
ous branches of the DDR, mobilizing this intricate network
in a concerted manner (10–14). ATM is a serine-threonine
protein kinase with a PI3-kinase signature. It is a member
of the PI3 kinase-related protein kinase (PIKK) family. This
family includes, among others, the catalytic subunit of the
DNA-dependent protein kinase (DNA-PKcs), which is a
key player in the NHEJ branch of DSB repair and prob-
ably also in other genotoxic stress responses (15,16), and
ATR, which responds primarily to stalled replication forks
(17,18). The three protein kinases, which often collaborate
in maintaining genome stability, preferably phosphorylate
Ser or Thr residues followed by Gln (S/TQ motif).
Here, we report a novel, vital role for the COP9 signalo-
some (CSN) in the early phase of the DSB response, affect-
ing the choice between DSB repair pathways. CSN is a eu-
karyotic, evolutionarily conserved protein complex that is
located both in the nucleus and cytoplasm. It plays criti-
cal developmental roles in animals and plants by impact-
ing many signaling pathways (19–21). Not surprisingly, loss
of CSN subunits in the mouse is embryonic lethal (22,23).
CSN is composed of eight subunits (CSN1–8) that act as a
holoenzyme, with Zn2+-dependent isopeptidase activity re-
siding in subunit 5 (CSN5) (24). This activity removes a co-
valently conjugated ubiquitin-like protein, NEDD8, from
cullin proteins. Members of the cullin family (eight in mam-
mals) (25) serve as scaffolds in cullin RING ubiquitin lig-
ases (CRLs)––highly modular protein complexes that con-
stitute the largest group of ubiquitin E3 ligases (26–28).
CRLs are defined primarily by the nature of their cullin
scaffold and their numerous exchanging substrate receptor
modules. The continuous exchange of the substrate recep-
tors allows CRLs to act dynamically in different contexts
by affecting the turnover of various substrate proteins (28).
Part of the fine-tuned regulation of CRL activity is due
to cycles of NEDD8 conjugation onto a conserved lysine
residue at the carboxy terminal domains of the correspond-
ing cullins, and its removal. Neddylated cullins mark active
CRLs and deneddylation of their cullins reduces their activ-
ity (28,29). Importantly, a large fraction of CRLs appears
to be physically associated with CSN. CSN regulates CRL
activity both by deneddylating the corresponding cullins
and by sterically affecting their interaction with the cor-
responding E2 enzymes on one hand, and with their sub-
strates on the other (29–31). Cullin neddylation also in-
terferes with the association of the CSN-bound CRL to
the protein CAND1, which regulates substrate receptor ex-
change (29,32–34). Thus, CSN’s constant fine-tuning of the
architecture and activity of CRLs in numerous aspects of
cellular life make it a critical player in the same circuits.
Resolution of CSN’s structure has recently shown that it
lays inactive until it encounters its substrates––neddylated
cullins––which render it active (24).
CSN was previously shown to be involved in nucleotide
excision repair––a DNA repair pathway which specifically
handles bulky DNA lesions such as those caused by UV ra-
diation (35). This involvement is based on CSN-mediated
regulation of CRL complexes that contain cullin 4 (CRL4),
which take part in the initial recognition and subsequent re-
pair of UV-induced pyrimidine dimers (30,35–40).
Here, we reveal that CSN is a novel player in the vast sig-
naling network that is activated by DSBs. We demonstrate
that CSN is required for timely DSB repair and regulates
the critical choice between DSB repair pathways. Specif-
ically, CSN is required for the processivity of DNA deep
end-resection, an initial, key step in HRR. Thus, upon in-
duction ofDSBs, a portion of cellular CSN is recruited both
physically and functionally to serve the DSB response. Fur-
thermore, our data suggest that CSN’s functional partner
in the DSB response is CRL4. We also establish that CSN
is an ATM target and that the ATM-mediated phosphory-
lation on Serine 410 of its subunit, CSN3, is critical for its
function in theDDR.Remarkably, elimination of this phos-
phorylation alone is sufficient to cause an organismal and
cellular phenotype in the mouse. Thus, our results suggest
that CSN is a new key regulator of the DSB response.
MATERIALS AND METHODS
Cell lines
Human U2-OS, HEK-293, and CAL51 cells were cultured
in DMEMwith 10% fetal bovine serum at 37◦C in 5% CO2
atmosphere. U2-OS cells stably expressing ectopic GFP-
CSN3 were grown in the same medium supplemented with
0.5 mg/ml G418. MEFs were isolated frommouse embryos
on day E12.5–13.5 and cultured inHAMF-10mediumwith
20% fetal bovine serum at 37◦C in 3% O2 and 5% CO2
atmosphere in culture dishes pre-coated with 0.1% gelatin
(Sigma–Aldrich, St. Louis, MO, USA).
Chemicals, antibodies and immunoblotting
DharmaFECT1 transfection reagent was obtained from
Dharmacon (GEDharmacon, Lafayette, CO, USA). BrdU
and Neocarzinostatin (NCS) were obtained from Sigma–
Aldrich (St. Louis, MO, USA). The ATM inhibitor,
KU60019 (41) and the DNA-PK inhibitor, NU7441 (42)
were obtained from Tcris Bioscience (Bristol, UK). Anti-
53BP1 mouse monoclonal antibody was a generous gift
from T. Halazonetis, anti-53BP1 polyclonal antibody was
obtained from Novus Biologicals, LLC (Littleton CO,
USA), anti-pS139-H2AX (H2AX) polyclonal antibody
and polyclonal antibodies against CSN subunits 1, 3 and
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5 were obtained from Bethyl Laboratories, Inc. (Mont-
gomery, TX, USA), anti-RNF168, anti-H2A, anti-pS139-
H2AX monoclonal antibody and anti-BRCA1 antibod-
ies were obtained from Merck Millipore (Darmstadt, Ger-
many), anti-H4 was obtained from Abcam (Cambridge,
MA, USA), anti-HSC70 monoclonal antibody was ob-
tained from Santa Cruz Biotechnology Inc. (Santa Cruz,
CA, USA), and anti-Cullin 1 antibody was obtained
from Invitrogen Corporation (Camarillo, CA, USA). Anti-
mouse and anti-rabbit IgG, Alexa 488/568/633 were pur-
chased from Molecular Probes (Leiden, Netherlands), and
HRP-conjugated anti-rabbit IgG and anti-mouse IgG were
obtained from Jackson Immunoresearch Laboratories, Inc.
(West Grove, PA, USA). Anti-Cullin 4A was produced in
the Kurz laboratory. The phospho-specific antibody against
pS410 of CSN3 was produced by Bethyl Laboratories, Inc.
Immunoblotting was carried out as previously described
(43).
Immunoprecipitation
Cells expressing GFP-tagged proteins were lysed in HBSS
(340 mM sucrose, 15 mM Tris–Cl pH 7.5, 15 mM NaCl,
60 mM KCl, 10 mM dithiothreitol) in the presence of pro-
tease and phosphatase inhibitors. After 10 min on ice the
nuclear fraction was separated by centrifugation at 650 g for
3 min at 4◦C.Nuclei were lysed in RIPA buffer (50 mMTris,
pH 7.5, 15 mMNaCl, 1% Igepal, 0.1% sodium dodecyl sul-
fate, 0.5% sodium deoxycholate) in the presence of protease
and phosphatase inhibitors.GFP-trap reagent (ChromoTek
GmbH Martinsried, Germany) was used to immunopre-
cipitate the GFP-tagged protein. The immune complexes
were subsequently subjected to immunoblotting analysis.
Immunoprecipitation of endogenous proteins from whole
cell extracts was carried out using RIPA buffer to lyse the
cells and was followed by five consecutive washes with this
buffer.
RNA Interference
OnTarget Plus SMARTpool siRNAs targeting CSN
subunits were obtained from Dharmacon: CSN3 (L-
01149400), CSN1 (L-01227200) and CUL4A (L-012610).
CSN5 siRNA was custom designed by Integrated DNA
Technologies (IDT, Coralville, IA, USA) in order to target
the following sequence: AGAAGUACUUUACCUGAA
A. U2-OS cells were cultured to 30–50% confluence and
transfected with siRNA using DharmaFECT1 following
manufacturer instructions.
Clonogenic survival assay
CAL51-derived cells and MEFs were plated in triplicate at
densities of 100–3000 cells per 60 mm plate and incubated
for 24 h before exposure to various doses of NCS. After 2
weeks in culture, cell colonies were fixed and stained with
0.2% crystal violet in 50% ethanol. Colonies containing at
least 50 cells were counted under a dissection microscope.
Immunostaining
Detection of 53BP1, H2AX and Rad51, nuclear foci by
immunofluorescence staining was performed as described
previously (43). Nuclear foci were quantified using the Im-
ageJ software (http://imagej.nih.gov/ij/). 200–300 cells were
counted per time point.
DSB repair pathways assay
The NHEJ/HRR balance assay was carried out as previ-
ously described (44), using U2-OS cells harboring a single
copy of the SeeSaw 2.0 Reporter. Briefly, 5000 cells were
plated on a 96-well plate. The cells were transfected with
siRNAs using RNAiMAX (Life Technologies, Grand Is-
land, NY, USA), and 2 days later were infected with a
lentiviral vector expressing BFP-tagged I-SceI (45), at mul-
tiplicity of infection 5, and fresh medium was added 24
h later. Forty-eight hours later, the cells were fixed with
4% paraformaldehyde and washed with phosphate buffered
saline (PBS) prior to scoring under a fluorescentmicroscope
for blue, green and red fluorescence. NHEJ/HRR balance
was calculated according to the ratio of green versus red
cells, and this ratio was normalized against a control (irrele-
vant) siRNA. Statistical significance was determined using
the paired sample t test.
DNA end-resection
SMART (Single Molecule Analysis of Resection Tracks)
was performed as previously described (46). Briefly, U2-OS
cells transfected with either siRNA against CSN1 or a con-
trol siRNA were cultured in the presence of 10 M bro-
modeoxyuridine (BrdU) for 24 h, irradiated with 10 Gy of
IR and harvested 1 h later. Cells were embedded in low-
melting agarose and in-gel DNA extraction followed. To
stretch the DNA fibers, silanized coverslips (Genomic Vi-
sion, Bagneux, France) were dipped into the DNA solution
for 15 min and pulled out at constant speed (250 m/s).
Coverslips were baked for 2 h at 60◦C and incubated with-
out denaturation with an anti-BrdUmouse monoclonal an-
tibody. After washing with PBS, coverslips were incubated
with a secondary antibody. The coverslips were mounted
with ProLong R©GoldAntifadeReagent (Molecular Probes)
and stored at −20◦C. DNA fibers were observed using a
Nikon NI-E microscope under a PLAN FLOUR40×/0.75
PHL DLL objective. The images were recorded and pro-
cessed using NIS ELEMENTS Nikon software. For each
experiment, at least 200 DNA fibers were analyzed, and the
length of DNA fibers was measured using Adobe Photo-
shop CS4 Extended version 11.0 (Adobe Systems Incorpo-
rated). Statistical significance in these experiments was de-
termined with the paired Student’s t-test using the PRISM
software (Graphpad Software Inc.).
Induction of localized DNA damage
In order to detect recruitment of ectopic, GFP-tagged pro-
teins to laser-induced DNA damage in live cells, U2-OS
cells were plated on glass bottom dishes (MatTek) and pre-
sensitizedwith 5MBrdU for 48 h at 37◦C. The dishes were
transferred into a microscope top-stage incubator equipped
with a control system for gas mixture and humidity (Oko-
lab, Ottaviani, Italy). DNA damage was induced on a Le-
ica TCS SP8 confocal microscope (Leica Microsystems,
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Wetzlar, Germany) using a 405 nm Diode laser focused
through an HC PL APO 63×, 1.4-numerical aperture oil
immersion objective (8% laser power, scan speed 650 ms, 40
scans). Images were acquired using the same system. In or-
der to detect recruitment of endogenous proteins to laser-
induced sites of DNA damage by immunostaining, two-
photon based micro-irradiation of DNAwas performed us-
ing a focused 800 nm laser beam in LSM 510 Meta confo-
cal microscope (Carl Zeiss, Jena, Germany) equipped with
a Spectral-Physics Mai-Tai (Deep-See) multi-photon laser
system focused through a 63× 1.25NA oil immersion objec-
tive (8.5% laser power, scan speed 256 ms, 40 scans at zoom
×1). Imaging of the immunostained cells was subsequently
carried out using a Leica TCS SP5 confocal microscope.
Generation of the Csn3 S410A knock-in mouse
Targeting vectors were generated in Escherichia coli via
the Recombineering technique using BAC DNA. A bac-
terial artificial chromosome (BAC) clone spanning the
Cops3 genomic locus (bMQ 302C20) was obtained from
the 129S7/AB2.2 BAC clone library (the Sanger Insti-
tute), and served for subcloning. Further reagents and
protocols were obtained from the National Institutes of
Health, NCI-Frederick (see http://recombineering.ncifcrf.
gov for details). Homologous recombination was carried
out in SW102 bacteria as previously described (47). In
short, a point mutation leading to the S410A substitution
(TCA→GCA) was first introduced into the BAC clone us-
ing gal K selection. The targeting cassette was subsequently
retrieved via gap repair into the pBS-derived vector, pL253.
Insertion of a floxed neo cassette (red and green box) fol-
lowed. For each retrieval or insertion step, mini target-
ing arms of 250–500 bp containing the preferred restric-
tion sites were prepared using PCR. The targeting construct
was linearized and introduced into 129/Sv male ES cells,
which were subsequently doubly selected in medium con-
taining 200 g/ml G418 and 0.2 M fialuridine. Positive
clones were analyzed by Southern blotting using 5′ and 3′
probes (Supplementary Figure S7A) to distinguish between
the mutant and wild-type alleles. Targeted ES cells were mi-
croinjected into 129/Sv blastocysts. Embryos were trans-
ferred to pseudopregnant foster mothers. Founder animals
were identified by Southern blotting analysis of tail DNA
using the 5′ and 3′ probes. Further genotyping was carried
out using PCR (Supplementary Figure S7B).
RESULTS
CSN is an ATM target in response to induction of DNA dam-
age
Early studies of the ATM protein in our lab included a
search for ATM-interacting proteins using the two-hybrid
assay. A bait spanning ATM residues 1184–1583, which
contain a leucine zipper––a protein-protein interaction
motif––identified CSN subunit 8 (CSN8) as prey (Supple-
mentary Figure S1A). Co-immunoprecipitation of endoge-
nousATMandCSN8 supported the notion of a physical in-
teraction between them (Supplementary Figure S1B), rais-
ing the possibility of functional interaction between ATM
and CSN and possibly rendering CSN an ATM target.
In order to search for DNA damage-induced phosphory-
lation of CSN subunits in cells, we expressed these sub-
units in HEK293 cells as ectopic HA-tagged proteins, and
treated the cells with the radiomimetic drug neocarzinos-
tatin (NCS) concurrently with a protein phospho-labeling
pulse. This experiment revealed marked enhancement of
phospho-labeling of CSN subunit 3 (CSN3) following NCS
treatment (Supplementary Figure S1C). We further noticed
that in response to DNA damage induction, a portion
of CSN3 exhibited altered electrophoretic migration (‘gel
shift’) (Figure 1A and B). Since this band-shift was largely
abolished upon knockdown of ATM (Figure 1B), we as-
sumed that it represented ATM-mediated phosphorylation
of CSN3 in cells. In order to map the phosphorylation site,
we expressed mutant versions of CSN3 in cells. In each mu-
tant, one of its four S/TQ sequences––potential ATMtarget
sites––was abolished by Ser→Ala substitutions. Only the
S410A substitution eliminated the band-shift (Figure 1A),
suggesting that the presumed phosphorylation occurred on
Ser410. A polyclonal phospho-specific antibody raised to
detect this assumed phosphorylation reacted strongly with
ectopic wild-type CSN3 expressed following NCS treat-
ment, but not with an S410Amutant version of this protein
(Figure 1C). This result indicated that phosphorylation of
CSN3 on Ser410 occurred in cells in response toDNAdam-
age and was detected by the antibody. The antibody also
detected the phosphorylation of endogenous CSN3, which
was ATM- and dose-dependent (Figure 1D–G), and DNA-
PK independent (Figure 1F); it peaked within 30 min of
damage induction and subsided several hours later––a time
course typical of many ATM-mediated protein phosphory-
lations (Figure 1G). These results established that Ser410
of CSN3 is an ATM target in response to DSB induction
and suggested a role for CSN in the ATM-mediated DSB
response.
CSN is required for regulation of DSB repair
We further examined the role of CSN in the DSB response
by measuring the cellular sensitivity of cells depleted of
CSN subunits CSN1 or CSN3, to the cytotoxic effect of
NCS, using RNAi. Deficiency of DDRplayers that disrupts
DSB repair or interferes with the fine balance between DSB
repair pathways usually results in cellular hypersensitivity
to DSB-inducing agents. This defective phenotype is typ-
ically measured by clonogenic survival assays. Since CSN
functions as a holoenzyme (24), loss of specific subunits is
expected to compromise its integrity and activity. We ob-
served that depletion of CSN1 led to concomitant depletion
of two other CSN subunits, CSN3 and CSN5, as did CSN3
depletion with regard to CSN1 and CSN5 (Supplementary
Figure S2). Knockdown of the catalytic subunit, CSN5, did
not lead to either CSN1 orCSN3 depletion (Supplementary
Figure S2), but presumably rendered CSN inactive. Deple-
tion of either CSN1 or CSN3 increased cellular sensitivity
to radiomimetic treatment (Figure 2A and B), suggesting
that down-regulation of CSN affected DSB repair.
Several assays have been developed in order to assess in-
dividually the efficiency of the two main pathways of DSB
repair, NHEJ andHRR, in cultured cell lines. A recently es-
tablished assay measures the ratio between these two path-
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Figure 1. CSN3 is an ATM substrate in the DNA damage response. (A) Mapping of the phosphorylation site on CSN3. Potential ATM targets in this
protein (serine or threonine residues followed by glutamine) were mutated in recombinant HA-tagged CSN3, and the various versions of the protein
were expressed in HEK293 cells. The band-shift observed after DNA damage induction (500 ng/ml of NCS for 30 min) was specifically abolished by
the S410A substitution, indicating that the corresponding modification occurred on S410. (B) Phosphorylation of S410 of CSN3 in response to DNA
damage induction is ATM-dependent. The experiment described in (A) was repeated in HEK293 cells that stably expressed shRNA against ATM. Note
the considerable reduction in CSN3’s band-shift in cells depleted of ATM. (C) Detection of CSN3 phosphorylation in cells using a specific anti-phospho
antibody. GFP-tagged CSN3 in wild-type and mutant (S410A) versions was ectopically expressed in U2-OS cells. Following treatment with 50 ng/ml of
NCS for 1 h, ectopic CSN3 was immunoprecipitated using an anti-GFP antibody, and the immune complexes were blotted with the indicated antibodies.
The ectopic wild-type protein, but not the mutant, reacts with the antibody after induction of DNA damage. In cellular extracts, the anti-phospho antibody
detects the phosphorylation of another protein in response to DNA damage (asterisk). Note that endogenous CSN1 and CSN5 are pulled down by ectopic
CSN3. (D) Depletion of CSN3 or ATM markedly reduces the pS410-CSN3 phosphorylation signal. U2-OS cells transfected with the indicated siRNAs
were treated 72 h later with 50 ng/ml of NCS for 30 min and processed for immunoblotting analysis. (E) CSN3 phosphorylation is dose- and ATM-
dependent. HEK293 cells expressing irrelevant (LacZ) or ATM shRNA were treated for 1 h with various doses of NCS, followed by immunoblotting with
the indicated antibodies. (F) CSN3 phosphorylation is not dependent on DNA-PK. U2-OS cells were treated with the indicated inhibitors 30 min prior to
treatment with 50 ng/ml of NCS. Phosphorylation of the ATM substrate KAP-1 on S824 served to monitor ATM activity in response to DNA damage
induction. ATMi: the ATM inhibitor, KU60019 (41), applied at 5 M concentration. DNA-PKi: the DNA-PK inhibitor, NU7441 (42) applied at 10 M
concentration. (G) Time course of phosphorylation of endogenous CSN3 following treatment of U2-OS cells with 50 ng/ml of NCS.
ways (44). Abrogation of either repair pathway disturbs the
finely regulated equilibrium between the two mechanisms,
such that deficiencies in DDR players that abrogate HRR
increase the NHEJ/HRR ratio, and vice versa. Deviation
from the normal ratio between NHEJ and HRR can lead
to defective DSB repair (44,48–50). To determine this ratio,
we used U2-OS cells whose genome contains the SeeSaw
Reporter (44) (SSR 2.0; Figure 2C), which harbors a cleav-
age site of the meganuclease I-SceI, that normally does not
cleave human DNA. Following I-SceI-mediated cleavage in
these cells, repair of the break by NHEJ leads to green GFP
fluorescence whereas repair viaHRR leads to redRFP fluo-
rescence, and the ratio between the two is determined. The
reporter is constructed such that direct, error-free ligation
of the sticky ends formed by I-SceI is prevented. Figure 2D
shows that down-regulation of either CSN1 or the catalytic
subunit, CSN5, in these cells increased the NHEJ/HRR ra-
tio similarly to the effect of CtIP down-regulation. CtIP is
an important regulator of theNHEJ:HRRbalance as it reg-
ulates DNA end-resection––an essential step toward HRR
(3,51). This effect is comparable to that obtained by the de-
pletion of several other DDR players, such as those that
mobilize major ubiquitin-driven DDR pathways (44). Im-
portantly, this effect was not due to abrogation of cell cycle
dynamics as a result of CSN depletion, as this depletion did
not affect the cell cycle distribution (not shown).
HRR reduction could be attributed to reduced efficiency
of a key step in this repair pathway––deep 5′ to 3′ resection
at each DSB ends. This step promotes HRR while inhibit-
ingNHEJ and is therefore highly regulated (52,53). In order
to assess the effect of CSN depletion on end-resection pro-
cessivity we used SMART (Single Molecule Analysis of Re-
section Tracks)––a recently developed, high-resolution as-
say that measures the extent of end-resection directly at the
DNA level (54). Importantly, CSN1 depletion significantly
reduced the length of resected DNA in IR-treated cells, to a
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Figure 2. Depletion of CSN subunits affects the DNA damage response. (A) Clonogenic survival assay of CAL51 cells transfected with siCSN1 or siCSN3
for 72 h. The cells were treated with various concentrations of NCS. Cells transfected with siATM or siGFP served as controls. (B) Extent of protein
depletion in the experiment depicted in (A). Note the reduction in CSN3 amounts in cells deleted of CSN1. (C) Schematic representation of the SeeSaw 2.0
reporters (44). A GFP ORF is flanked by two truncated parts of an RFP ORF (RF and FP) sharing 302 bp of homologous sequence. Two I-SceI-target
sites in opposite orientation are present at the 3′ end of the GFP ORF. After generation of a DSB by ectopic I-SceI endonuclease, it may be repaired via
NHEJ, and the cells will retain GFP expression, or it may be repaired via HRR, creating a functional RFP ORF. (D) Effect of the indicated siRNAs in the
SSR 2.0 assay. Two CSN subunits were knocked down: CSN1, whose depletion leads to reduction of other CSN subunits (Supplementary Figure S2), and
CSN5, which harbors the catalytic site of CSN’s deneddylase activity. The ratio of green to red cells in each condition was calculated and normalized for
each siRNA against the effect of a scrambled siRNA. Increased NHEJ/HRR ratio over the baseline value of 1.0 represents an imbalance between the two
DSB repair pathways toward NHEJ. The data represent four sets of triplicate experiments. Paired t test was used for statistical analysis. Asterisk indicates a
P value of <0.05. (E) Single Molecule Analysis of Resection Tracks (SMART) analysis of cells depleted of CSN1 or the end-resection regulator, CtIP, and
control cells. The length of individual fibers was measured as described in the ‘Materials and Methods’ section and the median of at least 250 fibers was
calculated. The average of the medians and the standard deviation of three independent experiments are shown. Note the marked reduction in resection
extent of CSN1-depleted cells compared to CtIP depletion (siControl-siCSN1: P = 0.0133; siControl-siCtIP: P = 0.0003).
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greater extent than that observed in cells depleted of CtIP,
a major regulator of this process (Figure 2E). We thus in-
ferred that CSN is a critical regulator of proper HRR by in-
fluencing end-resection, thereby affecting the maintenance
of the delicate balance between the major DSB repair path-
ways.
CSN is recruited to sites of DNA damage
The above data strongly suggested that CSN participates in
processes that occur at DSB sites. A common characteristic
of proteins that function at these sites is their temporary re-
cruitment to areas of chromatin spanning DSBs (4). Often,
only a portion of the cellular content of the protein is re-
cruited, but even the relocalization of such a small portion
can be demonstrated experimentally by targeting a narrow
nuclear sector with a focused laser beam to induce localized,
dense DNA damage, and subsequently imaging the protein
recruitment to that sector. Using this system, we were able
to observe recruitment of ectopic, stably expressed GFP-
tagged CSN3 to such ‘laser stripes’ as early as 30 s after
induction of DNAdamage, culminating within several min-
utes (Figure 3). This recruited fraction was retained at the
damaged sites for several hours (not shown). Since immuno-
precipitation of ectopic CSN3 concomitantly pulls down
endogenous CSN1 and CSN5 (Figure 1C), we assume that
the recombinant protein is incorporated into the CSN com-
plex, and therefore its recruitment to DSB sites represents
the relocalization of the CSN holoenzyme to these sites.
The recruitment dynamics were largely similar for both
the wild-type and the S410A-mutant proteins (Figure 3).
Furthermore, the recruitment of wild-type CSN3 was not
affected by the addition of an ATM inhibitor, suggest-
ing that the ATM-mediated phosphorylation of CSN3 did
not play a major role in this process. Importantly, how-
ever, pre-treatment of the cells with the small molecule,
MLN4924––a selective inhibitor of the NEDD8-activating
enzyme (NAE) that initiates the neddylation process
(55)––abolished the recruitment of CSN3 but not of two
other DDR players expressed as ectopic proteins: polynu-
cleotide kinase phosphatase (PNKP) (Supplementary Fig-
ure S3), and the E3 ubiquitin ligase, RNF8 (not shown).
This is a striking situation, in which the recruitment of a
single DDR player to sites of DNA damage is differentially
inhibited by a small molecule.
These results indicate that CSN belongs to the growing
group of proteins that are summoned from their ordinary
duties in other physiologic arenas to function in the DDR.
In this case, CSN’s involvement in the DDR is dependent
on prior protein neddylation, suggesting that its role in the
DDRmight be associated with its activity as a deneddylase.
Depletion of CSN1, which leads to depletion of other CSN
subunits (Supplementary Figure S2), did not affect the re-
cruitment of several major players in the early stage of the
DSB response––specifically 53BP1, RNF168 and BRCA1
(Supplementary Figure S4)––indicating that CSN is not re-
quired for their recruitment to the damaged sites. CSNmay
therefore participate in a stage of the DSB response which
is crucial for well-timed DSB repair, but not in the initial
build-up of the protein hubs surrounding DSB sites.
Cullin 4A partners with CSN in the DSB response
Among the CRLs, CRL4 (which contains cullins 4A or
4B) has been reported to be involved in a variety of DNA
transactions, such as transcription, replication and repair
(56) and has been specifically shown to play a central role
in the sensing and repairing of bulky DNA lesions caused
by UV radiation, via the nucleotide excision repair (NER)
pathway (30,35–38,56–57). We asked whether a functional
link between CSN and CUL4A ubiquitin ligase exists in
the context of the DSB response. We used an antibody spe-
cific for human CUL4A (Supplementary Figure S5) to fol-
low the recruitment of endogenous CUL4A to laser stripes
induced in human U2-OS cells. Endogenous CUL4A was
rapidly recruited to sites of DNA damage (Figure 4A), and
gradually dissipated over the next 30 min (Figure 4C). No-
tably, recruitment of CUL4A depended on the presence of
both CSN3 (Figure 4A) and CSN1 (Supplementary Fig-
ure S6A), suggesting that this process requires a functional
CSN. Moreover, pre-treatment of the cells with the neddy-
lation inhibitor, MLN4924, markedly attenuated CUL4A’s
recruitment to sites of DNA damage (Figure 4C), without
affecting the recruitment of two other major DDR players
- 53BP1 (Figure 4C) and RNF168 (not shown). These re-
sults suggest that CUL4A accrual at sites of DNA damage
requires active NEDD8 turnover, since it is impaired by in-
hibiting either protein neddylation or cullin deneddylation.
Crucially, ATM inhibition did not interfere with CUL4A
recruitment (Supplementary Figure S6B), indicating that,
as with CSN recruitment, this process did not require phos-
phorylation of ATM targets.
ATM-mediated phosphorylation of CSN3 is required for
timely DSB repair
Most DDR players are recruited from other processes and
typically undergo PTMs that modulate their function or ac-
tivity in order to prepare them for their temporary tasks
in the DDR (6,8); ATM-dependent phosphorylation is a
paramount example for such a PTM in the DSB response
(11). The results above suggested that ATM-mediated phos-
phorylation of CSN3may not play a critical role in its phys-
ical recruitment to sites of DNA damage. Is this phospho-
rylation necessary for CSN’s function in the DDR? Our
approach to studying the functional significance of this
phosphorylation was based on abolishing the phosphory-
lation site in murine Csn3 by knocking-in the correspond-
ing mouse gene, Cops3 such that it will produce a pro-
tein with an S410A substitution. An animal with a non-
phosphorylatable Csn3 exhibiting an organismal and cel-
lular phenotype would be valuable for demonstrating the
importance of this phosphorylation. The sequences of the
human and murine ortholog proteins share 99% identity,
and the amino acid sequence spanning Ser410 is identical
in the two proteins. TheCops3 gene was thus targeted to in-
duce the appropriate amino acid substitution in its protein
product (Supplementary Figure S7).
Mice homozygous for the mutant Cops3 allele expressed
normal levels of Csn3 (Figure 4A). As expected, follow-
ing whole body X-irradiation, Csn3 was not phosphory-
lated in tissues of these animals, contrary to another Atm
substrate, Kap-1 (Figure 5A). These mice grow normally,
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Figure 3. Recruitment of ectopic, GFP-tagged CSN3 to sites of laser-induced DNA damage. U2-OS cells stably expressing ectopic, GFP-tagged CSN3 in
wild-type or mutant (S410A) versions were either treated or not with 3 M of the neddylation inhibitor, MLN4924, for 6 h. Laser micro-irradiation was
then carried out and images captured in live cells at the indicated time points. Experiments were carried out in at least 15 cells. Representative cells are
shown. In the bottom panel, red arrows and green lines indicate the location of laser-induced damage in bright-field images of the irradiated cells.
have a normal life span and do not exhibit excessive mor-
bidity, suggesting that the S410A amino acid substitution
in Csn3 does not considerably affect CSN function un-
der normal conditions. Significantly, however, these mice
exhibited increased radiosensitivity that was intermediate
between that of wild-type and Atm−/− knockout mice
(Figure 5B). Moreover, mouse embryo fibroblasts (MEFs)
with non-phosphorylatable Csn3 showed NCS sensitivity
that was intermediate between that of wild-type and Atm-
deficient MEFs (Figure 5C), similar to human cells with
down-regulated CSN subunits (Figure 2A). In order to
monitor DSB repair in these cells, we followed the dynam-
ics of two hallmarks of unrepaired DSBs in MEFs treated
with ionizing radiation: nuclear foci of phosphorylated hi-
stone H2AX (H2AX) (58), and nuclear foci of the DDR
player 53BP1 (59). The gradual disappearance of both of
these DSB features was retarded in MEFs expressing the
mutant Csn3 (Figure 5D and E), attesting to a perturba-
tion of DSB repair in these cells. The results therefore in-
dicate that CSN’s involvement in DSB repair relies on the
ATM-mediated phosphorylation of CSN3, although this
phosphorylation does not seem to play a role in the phys-
ical recruitment of CSN to the sites of DNA damage.
In view of the result suggesting reduced HRR in human
cells depleted of CSN subunits (Figure 2D), we applied an
immunofluorescent assay to the MEFs in order to assess
successful initiation of HRR.We quantified the nuclear foci
of a major HRR player, Rad51, which coats DNA single
strand stretches following deep end-resection. Remarkably,
at various time points following IR treatment, the fraction
of cells with Rad51 nuclear foci in the mutant MEFs was
significantly lower than in wild-type cells (Figure 5F), at-
testing to a reduction in deep end-resection at DSB sites
in the mutant MEFs. The organismal and cellular pheno-
types associated with the loss of just one of the numerous
ATM-mediated phosphorylations (11) are notable and sug-
gest that this phosphorylation plays a crucial role in the
DDR, specifically in determining DSB repair efficiency.
DISCUSSION
Our results establish CSN as a new, crucial player in the cel-
lular response to DSBs, and place it at a critical decision
point in DSB repair, together with CRL4. Furthermore, we
show that the loss of a single ATM-mediated phosphoryla-
tion on one CSN subunit is sufficient to affect the organis-
mal and cellular response to DSBs.
The DDR network is based on a highly efficient and eco-
nomic system which temporarily borrows functional mod-
ules from other processes and adapts them to the needs of
the DDR, often by inducing PTMs on their key targets (1–
2,11). The dynamic organization ofCRLs that endows them
with a special capacity to alter their substrate specificity (28)
makes them ideal candidates for such a scenario. Our data
indicate that CSN and CRL4 are temporarily adapted and
recruited to serve the DSB response. Abrogation of CRL4
recruitment in CSN-depleted cells as well as the similar in-
hibition of CSN and CUL4A recruitment by the neddyla-
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Figure 4. Recruitment of cullin 4A to sites of laser-induced DNA damage is CSN- and neddylation-dependent. (A) Localized DNA damage was induced
using a focused laser microbeam in U2-OS cells transfected with the indicated siRNAs. At various time points after DNA damage induction the cells
were processed for immunostaining with the indicated antibodies. (B) Extent of knockdown of different proteins in this experiment demonstrated using
immunoblotting. Note that down-regulation of CSN subunits does not affect CUL4A levels, and vice versa. (C) Similar experiment as in (A), with treatment
of the cells with 3 M of the neddylation inhibitor, MLN4924, for 6 h prior to damage induction.
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Figure 5. Elimination of the Atm phosphorylation site on murine endogenous Csn3 impairs the DSB response in mice. (A) Endogenous Csn3 is not phos-
phorylated on S410 in response to DSBs in various tissues of mice expressing a mutated protein with the S410A amino acid substitution. Ten-day-old
mice were irradiated with 10 Gy of IR, and 1 h later tissues were collected and processed for immunoblotting analysis with the indicated antibodies. Phos-
phorylation of the Atm substrate Kap-1 on S824 served to monitor ATM activity. (B) Kaplan–Meier survival curve of 1-month old mice with various
genotypes in the Cops3 locus encoding Csn3 following whole body irradiation with 6.5 Gy of IR. 10–20 animals of each genotype were irradiated. (C)
Clonogenic survival of MEFs with different genotypes after treatment with various NCS doses. Cells expressing non-phosphorylatable Csn3 exhibit inter-
mediate radiomimetic sensitivity between that of wild-type and that of Atm-deficient cells. (D and E). Lack of an Atm phosphorylation site on Csn3 slows
the disappearance of DNA damage-induced H2AX and 53BP1 nuclear foci. MEFs with the indicated version of endogenous Csn3 were irradiated with
1 Gy of IR, and subsequently fixed and stained with antibodies against H2AX or 53BP1. Nuclear foci were counted in 150–250 cells per time point. (F)
Similar analysis as in (D) and (E) using an antibody against Rad51. The diagram presents the fraction of cells which contained more than 15 nuclear foci.
Experiments were carried out in triplicate, and one set of results is shown. Error bars represent SEM. Statistical analysis was based on Student’s t test for
H2AX, 53BP1 and χ2 for Rad51.
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tion inhibitor,MLN4924, suggests that CSN and CRL4 are
bound together in the same process that requires protein
neddylation dynamics.
Our data also demonstrate a role for this process
in the regulation of a key step in HRR––DNA end-
resection––which appears to be under very tight regulation
(52,53) and subsequently, affects the ratio between HRR
and NHEJ. There is growing appreciation for the role of
this critical balance in making DSB repair a well-timed and
smooth process, and, accordingly, of its subjection to sev-
eral regulatory mechanisms (9,44). Presumably, the involve-
ment of CSN and CRL4 in this process is due to ubiquity-
lation of CRL substrate(s) at the sites of DNA damage.
In the nucleotide excision repair pathway, which repairs
bulky DNA adducts, recognition of the DNA lesion by the
substrate receptor, DDB2, triggers the dissociation of CSN
from the CRL4DDB2 complex, thereby enhancing its activ-
ity, which is subsequently directed to NER players and core
histones at the damaged sites (30,38). It was recently shown
that inositol hexakiphosphate kinase-1 (IP6K1) is involved
in UV damage-induced dissociation of CSN from CRL4
(40). Interestingly, IP6K1 was previously shown to be re-
quired for theHRRbranch ofDSB repair (60). In our study,
we found that in the DSB response, CUL4A and CSN are
recruited to the damaged sites with roughly similar kinetics.
Analogous to the NER scenario, CRL4 and CSN might be
initially complexed, with their subsequent disengagement
leading to modulation of CRL4 activity and substrate re-
ceptor exchange. It will now be important to identify the
substrate receptor(s) engaged by the recruited CRL4 out
of the 50 or so that characterize CRL4s (56), to examine
whether CSN is involved in regulation of their exchange at
DSB sites, and to identify the relevant downstream CRL4
substrates.
ATM-mediated phosphorylation is an important PTM
in the recruitment of functional modules from other pro-
cesses to DDR service. ATM phosphorylates a vast num-
ber of downstream substrates in the DDR (11–13). Our re-
sults with knock-inmice expressing themutant S410ACsn3
and with cells derived from them, demonstrate that an im-
portant phosphorylation can be singled out of this noisy
background if it has high functional significance. It is in-
teresting that this single phosphorylation plays a crucial
role in accumulation of RAD51 at sites of DSBs, suggest-
ing that it directly impacts the deep end-resection which is a
pre-requisite for HRR. Notably, putative phosphorylation
of Ser410 of CSN3 was noticed in two proteomic screens
that studied phosphoproteome dynamics in response to IR
(12) or to the topoisomerase II inhibitor, etoposide, a DSB
inducer (61). Our data, together with the visibility of this
phosphorylation in proteomic screens, mark it as a highly
significant event in the DSB response in general. Recent
mass-spectrometric analysis of CSN subunits after treat-
ment of cells with UV radiation suggested that several sites
are phosphorylated on CSN in that context too, but these
sites were not further validated and their functional sig-
nificance was not examined (62). It will not be surprising,
however, if this modification shapes CSN’s action in the nu-
cleotide excision repair pathway as well.
Our data do not point to Ser410 phosphorylation as im-
portant for CSN recruitment to sites of DNA damage; thus,
its functional significance should be sought in the possi-
ble modulation of CSN’s activity through highly dynamic
engagement with its neddylated cullin substrates (29,63).
ATM typically phosphorylates more than one protein in a
pathway and even within the same protein complex (11). In-
deed, in the phosphoproteomic screen for ATM/ATR tar-
gets carried out by Matsuoka et al. (12), Ser232 of CSN
subunit 7A was a hit, in addition to Ser410 of CSN3. Im-
portantly, both serine residues are located in the carboxy-
termini of the corresponding CSN subunits. The recent elu-
cidation of CSN structure by Lingaraju et al. (24) revealed
that the carboxy termini of all CSN subunits, which typi-
cally contain -helices, protrude out of themain body of the
CSNparticle and together form a helical bundle. Thus, both
ATM-mediated phosphorylations of CSN fall within this
helical bundle. Lingaraju et al. (24) suggested that the heli-
cal bundle enables the catalytic subunit, CSN5, to sense the
assembly state of CSN and become activated in the presence
of a CRL substrate. We assume, therefore, that together,
these phosphorylations affect the substrate recognition of
CSN in the microenvironment of the protein hubs that as-
semble at sites of DNA damage. CSN’s multi-pronged regu-
lation of CRL architecture (28) may further impact the sub-
strate receptor exchange of the interacting CRL, and subse-
quently, the ubiquitylation of specific proteins by that CRL.
Notably, in the CSN structure, CSN3, which is an ATM tar-
get, andCSN8, which anchorsATM toCSN, are positioned
adjacent to each other and close to the substrate receptor in
the CSN-bound CRL (24). Work is in progress to identify
the substrate receptor in the fraction of the CRL4 complex
that is recruited to serve theDDR, and the downstream sub-
strate of this CRL4 fraction.
All this converges to meticulous regulation of CRL4 at
DSB sites, within the protein conglomerates that span these
lesions. Such fine regulation of protein ubiquitylation agrees
with the growing notion that this PTM must be carefully
fine-tuned in the DDR and is therefore subjected to delicate
checks and balances (7). In this context, the fine interplay
between CRLs and their major regulator, CSN, is emerging
as an important pathway regulatory junction, safeguarding
the complex system of genome stability.
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